Highlights from the International Myeloma Society (IMS) annual meeting 2025Conferences, Myeloma24 September 2025
Join our upcoming MPE and ASCERTAIN webinar on cost-effectiveness analysisMPE, Myeloma23 September 2025
Shape your myeloma care: New MPE research highlights the power of shared decision-making in myeloma careMPE, Myeloma, Patient evidence2 September 2025
The European Commission grants final authorisation for belantamab mafodotin (Blenrep®) combinations for relapsed/refractory myeloma patientsMyeloma, News25 July 2025
New guidelines for the treatment and the management of myeloma and smouldering myelomaMyeloma, News14 July 2025
